A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients
Abstract A high intrapatient variability (IPV) in tacrolimus exposure is a risk factor for poor long‐term outcomes after kidney transplantation. The main objective of this trial was to investigate whether tacrolimus IPV decreases after switching patients from immediate‐release (IR)‐tacrolimus to eit...
Saved in:
Main Authors: | Kim L. W. Bunthof (Author), Linda Al‐Hassany (Author), Gizal Nakshbandi (Author), Dennis A. Hesselink (Author), Ron H. N. vanSchaik (Author), Marc A. G. J. ten Dam (Author), Marije C. Baas (Author), Luuk B. Hilbrands (Author), Teun vanGelder (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation
by: Cristina Dopazo, et al.
Published: (2022) -
Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation
by: Jean-Baptiste Woillard, et al.
Published: (2017) -
Factors influencing intrapatient variability of tacrolimus and its association with 1-year post-transplant outcomes in pediatric liver transplant recipients
by: Chuxuan Fang, et al.
Published: (2024) -
Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
by: Arnaud Del Bello, et al.
Published: (2021) -
Effect of the Interrelation between CYP3A5 Genotype, Concentration/Dose Ratio and Intrapatient Variability of Tacrolimus on Kidney Graft Function: Monte Carlo Simulation Approach
by: Nikola Stefanović, et al.
Published: (2021)